Celestica (NYSE: CLS) reported Q1 EPS of $0.16, $0.05 better than the analyst estimate of $0.11. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.25 billion.

• Significant uncertainty remains with respect to the future impact on our business of COVID-19. While our operations are largely stabilized, the size and geographic diversity of our network (36 manufacturing sites in 14 countries), exacerbates the high degree of variability surrounding government imposed workforce restrictions, impacting not only our operations but that of our global supply base. Therefore, and consistent with many of our large customers, we do not believe it would be prudent to provide specific financial guidance for Q2 2020 at this time. While we are not providing guidance, we currently anticipate that Q2 2020 results will be largely in line with our Q1 2020 results, should conditions neither improve, nor deteriorate further.

For earnings history and earnings-related data on Celestica (CLS) click here.